Tue, 8 December 2015
Are There Clinically Significant Differences Among the First and Second Generation EGFR TKIs (Iressa, Tarceva, Gilotrif)?
Drs. Ben Solomon, Leora Horn, & Jack West review whether the data and clinical experience suggest any clinically significant differences among the first and second generation EGFR TKIs (Iressa, Tarceva, Gilotrif/Giotrif).
Direct download: GRACEcast-410_WCLC_2015_Clinically_Significant_Differences_First_Second_Generation_EGFR_TKIs.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT